HINJ Holds Pulse 2026: Saving Lives Globally, Driving Our Economy Locally

Trenton, March 13, 2026 ― The HealthCare Institute of New Jersey (HINJ – www.hinj.org), hosted a forum today titled “Pulse:  Saving Lives Globally, Driving Our Economy Locally.”  Held at Middlesex College in Edison, this seminar was designed to inform industry leaders, policymakers, and stakeholders about the state of New Jersey’s life sciences and our leading […]

Health Care’s Huge Hidden Cost: Sherrill to Take Aim at PBMs (BINJE.com)

By Tom Bergeron March 11, 2026 Included in Gov. Mikie Sherrill’s Budget Address list of potential spending cuts and reforms around health care costs was a promise that caught the ear of the state’s incredibly important life sciences sector: PBM reform. Sherrill called PBMs — officially “Pharmacy Benefit Managers” — a “type of shadowy middleman” who […]

HealthCare Institute of New Jersey Statement on Governor Sherrill’s Budget Address PBM Remarks

Trenton, March 10, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning Governor Mikie Sherrill’s budget address remarks on pharmacy benefit manager reforms: “Common-sense PBM reform is one of the most effective and immediate ways to lower healthcare costs, and […]

NJ’s Life Sciences Boom (njbmagazine.com)

While more life sciences companies are choosing to locate and expand in New Jersey, a more competitive business climate could be the key to unlocking the industry’s full potential. By Jim Pytell, Managing Editor Mar 5, 2026 New Jersey has been known as “The Medicine Chest of the World” for well over a century. The […]

HealthCare Institute of New Jersey Statement on the State of the Union’s “Most Favored Nation” Drug Pricing Proposal

Trenton, February 25, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the “Most Favored Nation” drug pricing proposal referenced in last night’s State of the Union address: “New Jersey and America lead the world in drug discovery and curing […]

Healthcare Institute of New Jersey Statement on State Senate Confirmation of Dr. Stephen Cha as Department of Human Services Commissioner

Trenton, February 24, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the New Jersey State Senate’s confirmation of Dr. Stephen Cha as Commissioner of the Department of Human Services: “New Jersey’s life sciences community congratulates Dr. Cha on his […]

Op-Ed: Other States are Recruiting Away New Jersey’s Industry.  Here’s How We Stop Them.

by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) For over one hundred and fifty years, New Jersey has been known as the “Medicine Chest of the World.” Our state’s economy revolves around its innovation sector, which has been saving lives globally for generations. Life sciences companies in New Jersey contribute […]

HealthCare Institute of New Jersey Statement on the Sherrill Administration’s Economic Development and Innovation Report

Trenton, February 18, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the release of the Sherrill Administration’s Economic Development and Innovation Report: “We are excited to work with Governor Sherrill and her team to protect New Jersey’s status as […]